Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
- PMID: 33542907
- PMCID: PMC7851377
- DOI: 10.2147/JHC.S268291
Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
Abstract
After being overlooked for decades, circular RNAs (circRNAs) have recently generated considerable interest. circRNAs play a role in a variety of normal and pathological biological processes, including hepatocarcinogenesis. Many circRNAs contribute to hepatocarcinogenesis through sponging of microRNAs (miRs) and disruption of cellular signaling pathways that play a part in control of cell proliferation, metastasis and apoptosis. In most cases, overexpressed circRNAs sequester miRs to cause de-repressed translation of mRNAs that encode oncogenic proteins. Conversely, low expression of circRNAs has also been described in hepatocellular carcinoma (HCC) and is associated with inhibited production of tumor suppressor proteins. Other functions of circRNAs that contribute to hepatocarcinogenesis include translation of truncated proteins and acting as adapters to regulate influence of transcription factors on target gene expression. circRNAs also affect hepatocyte transformation indirectly. For example, the molecules regulate immune surveillance of cancerous cells and influence the liver fibrosis that commonly precedes HCC. Marked over- or under-expression of circRNA expression in HCC, with correlating plasma concentrations, has diagnostic utility and assays of these RNAs are being developed as biomarkers of HCC. Although knowledge in the field has recently surged, the myriad of described effects suggests that not all may be vital to hepatocarcinogenesis. Nevertheless, investigation of the role of circRNAs is providing valuable insights that are likely to contribute to improved management of a serious and highly aggressive cancer.
Keywords: HBV; HCC; biomarkers; ceRNA; circRNA; microRNA; signaling pathways.
© 2021 Ely et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures



Similar articles
-
Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.Cancer Biomark. 2018;22(4):631-640. doi: 10.3233/CBM-170910. Cancer Biomark. 2018. PMID: 29914004
-
CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.Clin Sci (Lond). 2019 Jul 15;133(13):1487-1503. doi: 10.1042/CS20190394. Print 2019 Jul 15. Clin Sci (Lond). 2019. PMID: 31278132
-
The Emerging Role of Circular RNAs in Hepatocellular Carcinoma.J Cancer. 2018 Apr 12;9(9):1548-1559. doi: 10.7150/jca.24566. eCollection 2018. J Cancer. 2018. PMID: 29760792 Free PMC article. Review.
-
Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression.Hepatology. 2017 Oct;66(4):1151-1164. doi: 10.1002/hep.29270. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28520103
-
Circular RNAs: Characteristics, Function and Clinical Significance in Hepatocellular Carcinoma.Cancers (Basel). 2018 Aug 2;10(8):258. doi: 10.3390/cancers10080258. Cancers (Basel). 2018. PMID: 30072625 Free PMC article. Review.
Cited by
-
The Emerging Roles of Circular RNAs in the Chemoresistance of Gastrointestinal Cancer.Front Cell Dev Biol. 2022 Jan 21;10:821609. doi: 10.3389/fcell.2022.821609. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35127685 Free PMC article. Review.
-
Impact of circ-0000221 in the Pathogenesis of Hepatocellular via Modulation of miR-661-PTPN11 mRNA Axis.Pharmaceutics. 2022 Jan 6;14(1):138. doi: 10.3390/pharmaceutics14010138. Pharmaceutics. 2022. PMID: 35057034 Free PMC article.
-
Transcriptome Analysis Reveals the Anti-cancerous Mechanism of Licochalcone A on Human Hepatoma Cell HepG2.Front Nutr. 2021 Dec 20;8:807574. doi: 10.3389/fnut.2021.807574. eCollection 2021. Front Nutr. 2021. PMID: 34988109 Free PMC article.
-
The function and regulation network mechanism of circRNA in liver diseases.Cancer Cell Int. 2022 Mar 31;22(1):141. doi: 10.1186/s12935-022-02559-1. Cancer Cell Int. 2022. PMID: 35361205 Free PMC article. Review.
-
Hsa_circ_0011385 knockdown represses cell proliferation in hepatocellular carcinoma.Cell Death Discov. 2021 Oct 1;7(1):270. doi: 10.1038/s41420-021-00664-0. Cell Death Discov. 2021. PMID: 34599150 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources